🔎 Trials Near Me

Beranda › Concord, CA

Studi relawan sehat di Concord, CA

12 studi di lokasi sekitar Concord menerima relawan sehat — orang tanpa kondisi yang sedang diteliti. Banyak studi membayar peserta atas waktu dan perjalanan mereka; jumlah pembayaran ditentukan oleh masing-masing studi, jadi tanyakan kepada tim studi.

Teks studi resmi (Bahasa Inggris)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • John Muir Medical Center-Walnut Creek, Walnut Creek · 5 mi jauhnya
  • Contra Costa Regional Medical Center, Martinez · 6 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults

Menerima pesertaFase 3Sukarelawan sehat diterima
  • Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek · 5 mi jauhnya
Usia 18 hingga 49 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07794748

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Menerima pesertaFase 3Sukarelawan sehat diterima
  • GSK Investigational Site, Walnut Creek · 5 mi jauhnya
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07805707

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

Menerima pesertaFase 3Sukarelawan sehat diterima
  • Kaiser Permanente Walnut Creek, Walnut Creek · 5 mi jauhnya
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07282665

Senicapoc in Alzheimer's Disease

Menerima pesertaFase 2Sukarelawan sehat diterima
  • UC Davis Alzheimer's Disease Center East Bay, Walnut Creek · 5 mi jauhnya
Usia 55 hingga 85 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04804241

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

Menerima pesertaFase 4Sukarelawan sehat diterima
  • Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek · 5 mi jauhnya
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT07730450

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

Menerima pesertaFase 3Sukarelawan sehat diterima
  • GSK Investigational Site, Walnut Creek · 5 mi jauhnya
15 Months – 6 Years · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT07406360

Molecular Genetics Studies of Cancer Patients and Their Relatives

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • John Muir Medical Center-Concord Campus, Concord
Semua usia · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT04185935

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

Menerima pesertaFase 3Sukarelawan sehat diterima
  • GSK Investigational Site, Walnut Creek · 5 mi jauhnya
12 Months – 15 Months · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT06740630

A Study to Learn About mRNA Vaccines Against Influenza in Adults

Menerima pesertaFase 2Sukarelawan sehat diterima
  • Diablo Clinical Research, LLC d/b/a Flourish Research, Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07431853

A Study to Learn About a Vaccine Against E Coli in Healthy Adults

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT07122986

Urine Metabolites in the Diagnosis of Disease

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Bass Medical Group (Gastroenterology), Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Des 2024 · NCT06710067

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.